BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 9400591)

  • 1. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
    Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
    Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
    J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
    J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H; Barloggio A; Egger M; Garweg JG;
    Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of CD4+ CD25hi regulatory T (Treg) cells to disease progression in HIV-infected patients].
    Song SJ; Feng X; Guo JJ; Iu YN; Lun WH; Wei HS; Liu SA
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):361-3. PubMed ID: 20387487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
    Netski DM; Mosbruger T; Astemborski J; Mehta SH; Thomas DL; Cox AL
    J Infect Dis; 2007 Mar; 195(6):857-63. PubMed ID: 17299716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
    Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals.
    Kelly HR; Urbanski M; Burda S; Zhong P; Konings F; Nanfack J; Tongo M; Kinge T; Achkar J; Nyambi P
    Hum Antibodies; 2005; 14(3-4):89-99. PubMed ID: 16720979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.
    Euler Z; van Gils MJ; Bunnik EM; Phung P; Schweighardt B; Wrin T; Schuitemaker H
    J Infect Dis; 2010 Apr; 201(7):1045-53. PubMed ID: 20170371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
    J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count.
    Kupfer B; Kaiser R; Rockstroh JK; Matz B; Schneweis KE
    J Med Virol; 1998 Nov; 56(3):259-63. PubMed ID: 9783695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.